RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

ClinicalTrials.gov ID: NCT06328777

Public ClinicalTrials.gov record NCT06328777. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 6, 2026, 8:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T Cells (CABA-201) in Subjects With Systemic Sclerosis

Study identification

NCT ID: NCT06328777
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 1, Phase 2
Lead sponsor: Cabaletta Bio; Industry
Enrollment: 12 participants

Conditions and interventions

Conditions

Interventions

CABA-201 Biological

Biological

Eligibility (public fields only)

Age range: 18 Years to 75 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 1, 2024
Primary completion: Jun 30, 2029
Completion: Jun 30, 2029
Last update posted: Apr 23, 2026

2024 – 2029

United States locations

U.S. sites: 10
U.S. states: 8
U.S. cities: 9

Facility	City	State	ZIP	Site status
Yale University	New Haven	Connecticut	06519	Recruiting
Mayo Clinic Florida	Jacksonville	Florida	55905	Recruiting
Northwestern Memorial Hospital	Chicago	Illinois	60611	Recruiting
The University of Chicago Medical Center	Chicago	Illinois	60637	Recruiting
University of Kansas Medical Center	Kansas City	Kansas	66160	Recruiting
University of Michigan	Ann Arbor	Michigan	48109	Recruiting
Mayo Clinic Rochester	Rochester	Minnesota	55905	Recruiting
Columbia University Irving Medical Center	New York	New York	10032	Recruiting
University of Rochester	Rochester	New York	14642	Recruiting
Duke University	Durham	North Carolina	27710	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06328777, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 23, 2026 · Synced May 6, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06328777 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →